回盛生物 (300871.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(回盛生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度销售毛利率(%) 23.0020.0019.0020.0024.0025.0022.0018.0020.00
 单季度销售净利率(%) -8.001.00--6.007.007.002.001.00
 单季度净资产收益率ROE(%) -1.00---1.002.001.00--
 单季度总资产净利率ROA(%) -1.00----1.001.00--
单季度财务摘要:
 单季度营业总收入(元) 206,809,092.00328,372,550.00242,303,822.00218,670,351.00230,412,076.00351,422,021.00274,460,009.00191,353,008.00205,665,755.00
 单季度营业总成本(元) 219,314,493.00327,282,562.00247,882,641.00220,650,953.00220,505,096.00314,555,648.00256,207,362.00190,840,823.00201,486,255.00
 单季度营业收入(元) 206,809,092.00328,372,550.00242,303,822.00218,670,351.00230,412,076.00351,422,021.00274,460,009.00191,353,008.00205,665,755.00
 单季度营业利润(元) -21,487,194.00-1,906,109.00-2,627,692.002,997,492.0016,619,294.0028,723,425.0020,068,009.005,566,418.004,799,097.00
 单季度利润总额(元) -21,546,000.00-2,199,086.00-2,722,581.00731,745.0016,631,467.0028,249,092.0020,055,513.005,611,103.002,793,791.00
 单季度净利润(元) -16,405,617.001,903,460.00-1,020,586.001,042,226.0014,855,718.0026,300,498.0019,893,334.004,488,789.002,023,855.00
 单季度归属母公司股东的净利润(元) -16,405,617.001,903,460.00-1,020,586.001,042,226.0014,855,718.0026,300,498.0019,893,334.004,488,789.002,023,855.00
 单季度经营活动产生的现金流量(元) -46,279,494.0035,859,133.0051,038,672.0023,201,776.00-17,180,234.0023,347,197.0047,518,472.0041,839,950.00-16,025,128.00
 单季度投资活动产生的现金流量(元) -76,332,192.0074,897,703.00-58,756,763.00-27,930,728.00-88,514,280.0051,086,969.00-109,698,125.00-314,481,505.00-376,449,232.00
 单季度筹资活动产生的现金流量(元) 95,204,303.00-422,730.00-83,123,216.00-22,525,537.0064,595,119.0020,444,389.0038,854,208.00-95,276,952.001,375,367.00
 单季度现金及现金等价物净增加(元) -27,762,908.00110,101,124.00-90,853,713.00-27,207,559.00-41,133,765.0094,747,844.00-23,281,786.00-367,930,470.00-391,070,067.00

前瞻产业研究院